CPC C07D 403/14 (2013.01) [A61P 25/28 (2018.01); C07D 403/04 (2013.01)] | 18 Claims |
1. A compound of Formula Ic:
or a pharmaceutically acceptable salt thereof, wherein:
A is N or N+—O—;
Q1 and Q2 are each independently selected from CH and N;
W is O, S, or NRN;
--- is a single bond;
X is CR5R6 and Y is CR8R9;
Ring Z is C6-10 aryl, C3-7 cycloalkyl, 5-10 membered heteroaryl, or 4-10 membered heterocycloalkyl;
RN is H, C1-4 alkyl, or CN;
R1 is halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
R2C is selected from H, C1-4 alkyl, C1-4 hydroxyalkyl, C1-4cyanoalkyl, and C3-7 cycloalkyl;
R3 and R5, together with the atoms to which they are attached and together with any intervening atoms, form a 5-7 membered heterocycloalkyl ring optionally substituted by 1, 2, or 3 substituents independently selected from oxo, halo, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, and C1-4 haloalkoxy;
each R4 is independently halo, nitro, cyano, C1-4 alkyl, C2-4 alkenyl, C2-4 alkynyl, C1-4 haloalkyl, C1-4 alkoxy, or C1-4 haloalkoxy;
R6, R8, and R9 are each independently selected from H, halo, NH2, OH, C1-4 alkyl, C1-4 haloalkyl, C1-4 cyanoalkyl, C1-4 alkoxy, and C1-4 haloalkoxy;
m is 0, 1, or 2; and
n is 0, 1, 2, 3, 4, or 5.
|